This monthly PMTCT (Prevention of Mother-to-Child
Transmission) report from Agaro General Hospital
(Meskerem 2018 – Megabit 2018) shows the following key
points:
[Link] Testing Among Pregnant & Lactating Women
-Total tested & knew results: 2,374 women
- During pregnancy: 689
- During labour & delivery: 1,685
- Postpartum period: 0
-New HIV-positive women identified:Only 2 (recorded in
Hidar 2018).
[Link] for PMTCT
-HIV-positive pregnant women who received ART: 4 total
- First-time ART during ANC: 0
- First-time ART during labour/delivery: 3
- First-time ART during postpartum: 1
[Link]-Exposed Infants (HEI) – Early Infant Diagnosis
(EID)
-Samples collected (within 12 months): 9
- 0–2 months: 8
- 2–12 months: 1
-Results returned (within 12 months): 10 (possibly includes
previous month’s samples)
- 0–2 months: 9 negative, 0 positive
- 2–12 months: 1 negative, 0 positive
[Link] Prophylaxis
-Co-trimoxazole started within 2 months of birth: 4 infants
-ARV prophylaxis for 12 weeks:4 infants
[Link] Delivery & Partner Testing.
-HIV-positive women who gave birth at health institution: 9
-Partner HIV testing: 0 (no data reported)
[Link] Testing by 18 Months
-Infants tested by 18 months: 2 (both negative)
Brief Summary
The hospital is actively offering PMTCT services, with good
HIV testing uptake (2,374 women). However,new HIV-
positive case identification among pregnant/lactating
women is very low (only 2), raising questions about either
low seroprevalence or possible under-detection. ART
initiation for PMTCT is limited (4 total), and partner testing
is completely absent. Early infant diagnosis sampling is
ongoing, with no positive cases detected in the reported
period. Infant prophylaxis coverage is modest (4–9
infants).
Monthly data of the PMTCT data from the report from
Meskerem to Megabit 2018).
Indicator Meskere Tikeme Hida Tahesa Tir Y
m t r s
Provision of PMTCT service (1=yes) 1 1 1 1 1
Pregnant/lactating women tested for 452 406 397 284 410
HIV & knew results
Tested during pregnancy 141 136 119 106 91
Tested during labour/delivery 311 270 278 178 319
Tested postpartum 0 0 0 0 0
New HIV-positive women 0 0 2 0 0
(ANC/L&D/Postpartum)
HIV+ pregnant women who 0 2 2 0 0
received ART for PMTCT
First-time ART during ANC 0 0 0 0 0
First-time ART during L&D 0 1 2 0 0
First-time ART during PNC 0 1 0 0 0
HEI – virologic test (sample 1 1 1 1 3
collected) within 12 months
0–2 months 1 1 1 1 2
2–12 months 0 0 0 0 1
HEI virologic test result received 0 5 0 0 3
within 12 months
0–2 months (negative) 0 5 0 0 2
2–12 months (negative) 0 0 0 0 1
Infants started on co-trimoxazole 1 1 2 0 0
within 2 months
HEI receiving ARV prophylaxis for 1 1 1 1 0
12 weeks
HIV+ women who gave birth at 1 4 2 1 1
health institution
Partners tested for HIV 0 0 0 0 0
HEI receiving antibody test by 18 0 0 0 0 1
months
Negative 0 0 0 0 1
Monthly Highlights
-New HIV-positive women were identified only in Hidar (2
cases).
-ART for PMTCT was given only in Tikemet (2 women) and
Hidar (2 women).
-First-time ART during labour occurred in Tikemet (1) and
Hidar (2); during PNC only in Tikemet (1).
-HEI virologic testing (samples) was consistent (1–3 per
month), peaking in Tir (3 samples).
-Results returned were highest in Tikemet (5 results, all
negative) and Tir (3 results).
-Co-trimoxazole prophylaxis peaked in Hidar(2 infants).
-Facility births among HIV+ women highest in Tikemet (4
births).
-No partner testing reported in any month.
-No positive HIV results among exposed infants in any
month (all negatives).